Back to VRCA

Capital Analysts, LLC → VRCA

Capital Analysts, LLC VRCA Position History

Verrica Pharmaceuticals Inc. • Healthcare

Quarters held
14
Latest value
$7K
Q3 2026
Peak value
$12K
First seen
Q3 2024

Dollar value over time

Show data table
PeriodPosition value
Q3 2024$9K
Q4 2024$9K
Q1 2025$7K
Q2 2025$11K
Q3 2025$6K
Q3 2025$6K
Q4 2025$12K
Q4 2025$12K
Q4 2025$12K
Q1 2026$8K
Q1 2026$8K
Q2 2026$9K
Q2 2026$9K
Q3 2026$7K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$7K1.5K——
Q2 2026$9K1.5K——
Q2 2026$9K1.5K——
Q1 2026$8K1.5K——
Q1 2026$8K1.5K——
Q4 2025$12K1.5K——
Q4 2025$12K1.5K——
Q4 2025$12K1.5K——
Q3 2025$6K1.5K——
Q3 2025$6K1.5K——
Q2 2025$11K21.3K——
Q1 2025$7K16.3K——
Q4 2024$9K13.3K——
Q3 2024$9K6.3K——

Other funds holding VRCA

Other Capital Analysts, LLC positions

STT-PG

SPDR SERIES TRUST

$267.4M
STT-PG

SPDR SERIES TRUST

$267.4M
STT-PG

SPDR SERIES TRUST

$265M
STT-PG

SPDR SERIES TRUST

$259.3M
STT-PG

SPDR SERIES TRUST

$259.3M
STT-PG

SPDR SERIES TRUST

$253.8M
STT-PG

SPDR SERIES TRUST

$253.8M
STT-PG

SPDR SERIES TRUST

$253.8M